{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:08:57Z","timestamp":1791554937298,"version":"4.3.4"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100016925","name":"Takeda Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hereditary angioedema (HAE) is a rare inherited disorder causing recurrent episodes of swelling that can be potentially life threatening. Treatment of HAE can be divided into on-demand treatment for swelling, and prophylaxis. The last UK consensus on HAE was in 2014 and since then, new medications for prophylaxis have been developed, with more drugs in the pipeline. International guidelines currently recommend the use of long-term prophylaxis (LTP) as the only way of achieving disease control and normalizing patient lives. Modern prophylactic medications are available in the UK, although access is restricted primarily by HAE attack frequency. To establish an updated view of UK clinicians and patients, a Delphi process was used to develop statements regarding LTP as well as other aspects of HAE management. There was consensus that UK access criteria for modern LTP agents based on numerical frequency of attacks alone are too simplistic and potentially disadvantage a cohort of patients who may benefit from LTP. Additionally, there was agreement that patients should be seen in expert centres, remote monitoring of patients is popular post-pandemic, and that the use of patient-reported outcome measures has the potential to improve patient care. Psychological health is an area in which patients may benefit, and recognition of this is important for future research and development.<\/jats:p>","DOI":"10.1093\/cei\/uxae020","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T07:03:20Z","timestamp":1709708600000},"page":"109-116","source":"Crossref","is-referenced-by-count":6,"title":["Prophylaxis in hereditary angioedema: a United Kingdom Delphi consensus"],"prefix":"10.1093","volume":"217","author":[{"given":"Patrick F K","family":"Yong","sequence":"first","affiliation":[{"name":"Department of Immunology, Frimley Health NHS Foundation Trust , Frimley , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Annals","sequence":"additional","affiliation":[{"name":"Hereditary Angioedema UK , Bridgwater , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Diwakar","sequence":"additional","affiliation":[{"name":"Department of Immunology, University Hospital of North Midlands NHS Trust , Stoke-on-Trent , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuayb","family":"Elkhalifa","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, Cleveland Clinic Abu Dhabi , Abu Dhabi , United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gompels","sequence":"additional","affiliation":[{"name":"Department of Immunology, North Bristol NHS Trust , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Oxford University Hospitals NHS Foundation Trust , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Yousuf","family":"Karim","sequence":"additional","affiliation":[{"name":"Hematopathology, Sidra Medicine , Doha , Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergy, Hull University Teaching Hospitals NHS Trust , Hull , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Metcalfe","sequence":"additional","affiliation":[{"name":"Hereditary Angioedema UK , Bridgwater , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Noorani","sequence":"additional","affiliation":[{"name":"Department of Immunology, Sandwell and West Birmingham NHS Trust , Birmingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathal","family":"Steele","sequence":"additional","affiliation":[{"name":"Regional Immunology Service, Royal Hospitals Belfast , Belfast , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorena","family":"Kiani-Alikhan","sequence":"additional","affiliation":[{"name":"Department of Immunology, Royal Free London NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomaz","family":"Garcez","sequence":"additional","affiliation":[{"name":"Department of Immunology, Manchester University NHS Foundation Trust , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"2024062013064220300_CIT0001","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med"},{"key":"2024062013064220300_CIT0002","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jaip.2023.04.035","article-title":"A national survey of hereditary angioedema and acquired C1 inhibitor deficiency in the United Kingdom","volume":"11","author":"Yong","year":"2023","journal-title":"J Allergy Clin Immunol Pract."},{"key":"2024062013064220300_CIT0003","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy"},{"key":"2024062013064220300_CIT0004","author":"NHS England"},{"key":"2024062013064220300_CIT0005","volume-title":"Lanadelumab for preventing recurrent attacks of hereditary angioedema","author":"NICE","year":"2019"},{"key":"2024062013064220300_CIT0006","volume-title":"Berotralstat for preventing recurrent attacks of hereditary angioedema","author":"NICE","year":"2021"},{"key":"2024062013064220300_CIT0007","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cei.12584","article-title":"C1 inhibitor deficiency: 2014 United Kingdom consensus document","volume":"180","author":"Longhurst","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"2024062013064220300_CIT0008","doi-asserted-by":"crossref","first-page":"adv00456","DOI":"10.2340\/00015555-3807","article-title":"Patient-reported outcome measures for angioedema: a literature review","volume":"101","author":"Brix","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"2024062013064220300_CIT0009","doi-asserted-by":"crossref","first-page":"e12135","DOI":"10.1002\/clt2.12135","article-title":"Comorbidities in hereditary angioedema-a population-based cohort study","volume":"12","author":"Sundler Bj\u00f6rkman","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"2024062013064220300_CIT0010","author":"Royal College of Physicians","year":"2022"},{"key":"2024062013064220300_CIT0011"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxae020\/57127067\/uxae020.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/217\/1\/109\/58288206\/uxae020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/217\/1\/109\/58288206\/uxae020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T13:07:30Z","timestamp":1718888850000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/217\/1\/109\/7624313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,8]]},"published-print":{"date-parts":[[2024,6,20]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxae020","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,3,8]]}}}